-
Sep 20, 2021, 10:33 am227 pts
Ars Technica
Enlarge / Vials of the Pfizer COVID-19 vaccine. (credit: SOPA images) Small doses of Pfizer's COVID-19 mRNA in children ages 5 to 11 appeared to produce strong antibody responses and comparable side effects to those seen in older age groups, according to the first top-line results from a Phase 2/3 clinical…
Trending Today on Tech News Tube
Tech News Tube is a real time news feed of the latest technology news headlines.
Follow all of the top tech sites in one place, on the web or your mobile device.
Follow all of the top tech sites in one place, on the web or your mobile device.



















